Related Experiment Video
Updated: Jul 31, 2026

13:12
Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
A "universal" human influenza A vaccine
W Fiers1, M De Filette, A Birkett
1Laboratory Molecular Biology, University Ghent & VIB, Ledeganckstreet 35, 9000 Ghent, Belgium. fiers@dmb.rug.ac.be
Virus Research
|May 28, 2004
Summary
A universal influenza A vaccine using the M2e protein on HBc particles effectively protects mice. This conserved antigen, when combined with adjuvants, induces high antibody titers for complete protection against infection.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Influenza A virus poses a significant global health threat.
- A universal vaccine targeting conserved viral components is highly desirable.
- The external domain of the M2-protein (M2e) is conserved across influenza A strains.
Purpose of the Study:
- To develop and evaluate a universal human influenza A vaccine candidate.
- To assess the immunogenicity and protective efficacy of M2e-based vaccines.
- To optimize vaccine constructs and adjuvants for enhanced immune responses.
Main Methods:
- Utilized hepatitis B virus core (HBc) particles as a carrier for the M2e antigen.
- Constructed various M2e-HBc fusion proteins and evaluated their immunogenicity.
- Administered vaccine candidates with different adjuvants (intraperitoneal and intranasal routes).
- Measured anti-M2e antibody titers (IgG2a) and assessed protection in mouse models.
Main Results:
- M2e presented on HBc particles induced high-titer antibody responses in mice.
- Vaccine constructs with appropriate adjuvants conferred complete protection against lethal influenza infection.
- Intranasal vaccination with LT(R192G) adjuvant showed promising results.
- Achieved anti-M2e IgG2a serum titers exceeding 10,000.
Conclusions:
- A universal influenza A vaccine based on the conserved M2e antigen is feasible.
- HBc particles serve as an effective carrier for M2e, eliciting strong humoral immunity.
- Optimized M2e-HBc vaccines with adjuvants provide complete protection, offering a promising strategy for influenza prevention.
Related Concept Videos
Viral Recombination
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
Cross-reactivity
Overview
Vaccinations
Overview
Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...
Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...

